| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 10238-21-8 | 格列本脲; N-[2-[4-[[[(環(huán)己氨基)羰基]氨基]磺酰基]苯基]乙基]-2-甲氧基-5-氯苯甲酰胺 | Glyburide; 5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide; Glibenclamide |  | C23H28ClN3O5S | 詳情 | 供應商 |
| 116714-46-6 | 雙苯氟脲; N-[[3-氯-4-[1,1,2-三氟-2-(三氟甲氧基)乙氧基]苯基]氨基甲�；鵠-2,6-雙氟苯甲酰胺 | Novaluron; N-[[3-Chloro-4-[1,1,2-trifluoro-2-(trifluoromethoxy)ethoxy]phenyl]carbamoyl]-2,6-difluorobenzamide |  | C17H9ClF8N2O4 | 詳情 | 供應商 |
| 284461-73-0 | 索拉非尼; 4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺 | Sorafenib; 4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide |  | C21H16ClF3N4O3 | 詳情 | 供應商 |
| 475207-59-1 | 甲苯磺酸索拉非尼; 4-{4-[3-(4-氯-3-三氟甲基苯基)酰脲]苯氧基}吡啶-2-甲酰胺對甲苯磺酸鹽 | Sorafenib tosylate; Sorafenib tosylate [USAN]; 1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate); 4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate); BAY 43-9006; Nexavar(R); Sorafenib tosylate; UNII-5T62Q3B36J; 2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, mono(4-methylbenzenesulfonate); |  | C28H24ClF3N4O6S | 詳情 | 供應商 |